Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
11/2000
11/30/2000WO2000071516A2 INHIBITORS OF FACTOR Xa
11/30/2000WO2000071515A2 INHIBITORS OF FACTOR Xa
11/30/2000WO2000071514A1 α-AMINO-β-SULFONYL HYDROXAMIC ACID COMPOUNDS
11/30/2000WO2000071511A2 INHIBITORS OF FACTOR Xa
11/30/2000WO2000071510A2 INHIBITORS OF FACTOR Xa
11/30/2000WO2000071508A2 INHIBITORS OF FACTOR Xa
11/30/2000WO2000071507A2 INHIBITORS OF FACTOR Xa
11/30/2000WO2000071493A2 INHIBITORS OF FACTOR Xa
11/30/2000WO2000071116A1 Process for the production of amorphous atorvastatin calcium
11/30/2000DE19924050A1 Verfahren zur Herstellung von Alken-Verbindungen Process for the preparation of alkene compounds
11/30/2000CA2374947A1 Inhibitors of factor xa
11/30/2000CA2374793A1 Inhibitors of factor xa
11/30/2000CA2374788A1 Inhibitors of factor xa
11/30/2000CA2374650A1 Inhibitors of factor xa
11/30/2000CA2374646A1 Inhibitors of factor xa
11/30/2000CA2374641A1 Inhibitors of factor xa
11/30/2000CA2373577A1 .alpha.-amino-.beta.-sulfonyl hydroxamic acid compounds
11/30/2000CA2372580A1 Substituted phenyl compounds with immunosuppressing activity and pharmaceutical compositions
11/30/2000CA2371904A1 Inhibitors of factor xa
11/29/2000EP1055658A2 Process for cis-1- 2-[4-(6-methoxy-2-phenyl-1,2,3,4-tetrahydronaphthalen-1-yl)phenoxy]ethyl pyrrolidine
11/29/2000EP1055653A2 Process for the preparation of alkenyl compounds
11/29/2000EP1054960A1 Heteroaromatic oligoamides as affinity ligands
11/29/2000EP1054906A1 Polymerization process with living characteristics and polymers made therefrom
11/29/2000EP1054865A1 Farnesyl transferase inhibitors
11/29/2000EP1054860A1 Process for the synthesis of 1,3-diols
11/29/2000EP1054858A1 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted-alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
11/29/2000CN1275123A Prostaglandin agonists and their use to treat bone disorders
11/28/2000US6153766 Catalytic hydrogenation of azido group of 4-azido-3-hydroxybutyric acid ester into an amino group while a basic catalyst catalyzes ring-closing intramolecular amidation of the ester without inhibiting hydrogenation
11/28/2000US6153764 Imidation of a perylene tetracarboxylic derivative pigment precursor by cyclization reaction with ammonia or an amine in solution of reaction mixture containing a second cyclic imide derivative which is non-pigmentary
11/28/2000US6153759 Herbicide comprising a 5-membered or 6-membered heterocyclic, saturated or unsaturated radical containing one to three hetero atoms selected from the group consisting of oxygen, sulfur and nitrogen
11/28/2000US6153662 Aromatic maleimides and methods of using the same
11/28/2000US6153626 For treating pain, gastrointestinal disorders, spinal cord injury
11/28/2000US6153624 Pyrrolidine and piperidine derivatives and treatment of neurodegenerative disorders
11/23/2000WO2000069823A1 Ion channel modulating agents
11/23/2000WO2000069819A1 Hydroxamic acid derivatives as matrix metalloprotease inhibitors
11/23/2000WO2000069817A1 Process for producing optically active azetidine-2-carboxylic acids
11/23/2000WO2000069816A1 Metabotropic glutamate receptor antagonists
11/23/2000WO2000069815A1 Ureido-substituted cyclic amine derivatives and their use as drug
11/23/2000WO2000069432A1 Remedies or preventives for diseases in association with chemokines
11/23/2000WO2000034237A3 Acetamide and substituted acetamide-containing thiourea inhibitors of herpes viruses
11/23/2000CA2373942A1 Remedies or prophylactis for diseases in association with chemokines
11/23/2000CA2373500A1 Hydroxamic acid derivatives as matrix metalloprotease inhibitors
11/22/2000EP1052986A1 Anti-inflammatory agents
11/22/2000EP1052984A1 Antibacterial agents
11/22/2000EP0827502B1 Methadone derivatives and protein and polypeptide methadone derivative conjugates and labels
11/22/2000CN1274361A Solution phase synthesis of oligonucleotides
11/22/2000CN1274345A Novel diamino compounds, polyamic acid, polyimide, liquid-crystal alignment film made from film of polyimide, and liquid-crystal display element containing same
11/22/2000CN1274288A Peptide-containing & alpha; -ketoamide cysteine and serine protease inhibitors
11/22/2000CN1058707C Process for synthesis of d1-trans-4-phenyl-5-0-chlorobenzyl-pyrrolidone-2
11/21/2000US6150527 Synthetic multimerizing agents
11/21/2000US6150431 Photopolymerization of at least one ethylenically unsaturated double bond in presence of a photoinitiator
11/21/2000US6150397 5-aroylnaphthalene derivatives as anti-inflammatory agents
11/21/2000US6150388 Indole derivatives as 5-HT1 agonists
11/21/2000US6150378 Peptidyl-containing α-ketoamide cysteine and serine protease inhibitors
11/21/2000US6150367 1-(4-arylpiperazin-1-yl)-3-(2-oxopyrrolidin-1-yl )propane or 1-(4-arylpiperazin-1-yl)-3-(2-oxopiperidin-1-yl )propane can be used as therapeutic agents for hypertension, ischemia, and other cardiovascular disorders
11/21/2000US6150344 Useful for treatment of diseases such as malaria and alzheimer's disease; compounds are attached to a solid support
11/21/2000US6149980 Perfluoroalkyl haloalkyl ethers and compositions and applications thereof
11/21/2000CA2203694C Cancer inhibitory peptides
11/21/2000CA2013048C Substituted aminopyrroles as stabilisers for chlorine-containing polymers
11/16/2000WO2000068196A1 N-substituted dihydropyrrole derivatives
11/16/2000WO2000068195A2 Substituted pyrrolidines as cell adhesion inhibitors
11/16/2000WO2000068194A1 Iminocyclitol inhibitors of hexoaminidase and glycosidase
11/16/2000WO2000067746A1 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors
11/16/2000WO2000015634A3 Hiv protease inhibitors
11/16/2000WO2000009103A3 N-linked sulfonamides of n-heterocyclic carboxylic acids or isosteres for vision and memory disorders
11/15/2000EP1052255A1 Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analgetics.
11/15/2000EP1051399A1 Phenylalanine derivatives useful as pharmaceutical agents
11/15/2000EP1051397A1 Method for preparing an n- (aliphatic or aromatic)carbonyl]-2-aminoacetamide compound and a cyclyzed compound
11/15/2000EP1051394A1 Potassium channel inhibitors
11/15/2000EP1051388A1 Method for producing optically active amino alcohols
11/15/2000EP1051169A1 Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases
11/15/2000EP0876342B1 Fluorinated melt additives for thermoplastic polymers
11/15/2000EP0842227B1 Azothiophenes
11/15/2000CN1273581A Method and reagents for N-alkylating ureides
11/14/2000US6147255 Topical and systemic treatment of dermatological complaints associated with keratinization disorder which has effect on differentiation and on proliferation
11/14/2000US6147253 N-protected/N-substituted-beta-amino-hydroxy sulfonates
11/14/2000US6147223 Lactacystin analogs
11/14/2000US6147188 Irreversible cathepsin or calpain inhibitors
11/14/2000US6147145 Vinyl monomers in which the vinyl bears a heteroatom selected from nitrogen, oxygen, sulfur and silicon and n-oxyl compound of a secondary amine which does not bear hydrogen on the alph-carbons to prevent premature polymerization
11/09/2000WO2000066618A1 Integrin receptor antagonists
11/09/2000WO2000066587A2 Polyamines and their use in therapy
11/09/2000WO2000066552A1 Method for producing a benzoylguanidine derivative
11/09/2000WO2000066551A1 Cyclic amide compounds, process for the preparation of the same and uses thereof
11/09/2000WO2000066528A2 Quinones for treatment of diseases
11/09/2000WO2000066522A1 Glucocorticoid receptor modulators
11/09/2000WO2000066175A2 Conjugates as therapies for cancer and prostate diseases
11/09/2000WO2000028981A3 Methods for treating, preventing, and reducing the risk of the onset of alzheimer's disease using an hmg coa reductase inhibitor
11/09/2000CA2372611A1 Quinones for treatment of diseases
11/09/2000CA2372173A1 Glucocorticoid receptor modulators
11/09/2000CA2371618A1 Cyclic amide compounds, their production and use
11/09/2000CA2371604A1 Integrin receptor antagonists
11/09/2000CA2368801A1 Conjugates as therapies for cancer and prostate diseases
11/08/2000EP1049694A1 Benzothiadiazoles and derivatives
11/08/2000EP1049662A1 Inhibitors of alpha4 mediated cell adhesion
11/08/2000EP0842166B1 Process for synthesizing carbapenem side chain intermediates
11/08/2000EP0769006B1 Small molecule inhibitors of rotamase enzyme activity
11/08/2000CN1272841A Novel lactam metalloprotease inhibitors
11/08/2000CN1058262C Novel 1-phenylalkanone 5-HT4 receptor ligands
11/08/2000CN1058261C Synthesis process for 3,4,5-mono- or polysubstituted pyrrolidone-2 compounds
11/07/2000US6143902 Semi-synthesis of paclitaxel using a protected c-2 hydroxyl protected-n-acyl (2r,3s)-3-phenylisoserine activated esters
1 ... 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 ... 404